EPILEPSY STUDY INCRIMINATES ASPARTAME

EPILEPSY STUDY INCRIMINATES ASPARTAME in  MEDICATIONS

By Dr. GLEN MABSON, Phd,
CEO: Epileptic Foundation of Maui dba Pacific Epilepsy Soc.
A Nonprofit Community Supported Public Foundation IRS 501-(C)(3)


The Pacific Epilepsy Society in affiliation with the Epileptic
Foundation of Maui has completed a seven year study on Epilepsy and
Seizures, finding that epilepsy is at an all time high in Hawaii and
the western states and Pacific Ocean Territories. There has been
a100% increase over the two previous years.  See EFM Survey, Freedom
of Info Act 2000-2008 & EFM Survey 1999-03

The most profound reason for the spectacular increase in seizures is
the inclusion of the drug   ASPARTAME in with the new larger sized
anti-seizure drugs: DILANTIN, DEPACOAT, TEGRATOL and several others
produced by major pharmaceutical corporations.  In 2007 the
manufacture of Dilantin changed the description of the 100 mg.
Dilantin,  changed the 100 mg white capsule with red stripe to a much
larger white capsule, orange on one end, which contains 100 mg of the
drug, plus aspartame. 150 people who took the new Dilantin capsule
found the seizure rate increased in every case. The Chemical
Pharmaceutical Engineer employee, in fear of his job would not reveal
his name, but said they were adding aspartame.   He said the new
larger orange & white Dilantin is also labeled 100 mg,

Dr. Allen Stein, Neurosurgeon, President of the Epilepsy Foundation
of Hawaii (a separate organization from the above) is sympathetic to
the makers of ASPARTAME and routinely prescribes these drugs. I
believe this contributes to the increase of epilepsy in these areas.

Glenn Mabson, PhD., CEO
Epileptic Foundation of Maui  (dba Pacific Epilepsy Society)
 808 879 8999